PAPD5 inhibitor (Redona therapeutics)

N/A

Report date: 2025/01/26 16:33:10
NME

Base Information

Drug NamePAPD5 inhibitor (Redona therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTerminal nucleotidyltransferase 4B inhibitors
TargetsTerminal nucleotidyltransferase 4B
Therapy Area/IndicationsDyskeratosis CongenitaHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRedona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRedona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDyskeratosis CongenitaHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A